According to Sun Pharmaceutical 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.52. At the end of 2025 the company had a P/S ratio of 7.92.
Year | P/S ratio | Change |
---|---|---|
2025 | 7.92 | -8.13% |
2024 | 8.62 | 33.9% |
2023 | 6.44 | 16.45% |
2022 | 5.53 | 2.54% |
2021 | 5.39 | 22.46% |
2020 | 4.40 | 34.91% |
2019 | 3.26 | -9.16% |
2018 | 3.59 | -32.02% |
2017 | 5.28 | 8.78% |
2016 | 4.86 | -32.65% |
2015 | 7.21 | 9.56% |
2014 | 6.58 | -12.96% |
2013 | 7.56 | 6.44% |
2012 | 7.10 |